GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (BOM:524500) » Definitions » Forward Dividend Yield %

Kilitch Drugs (India) (BOM:524500) Forward Dividend Yield % : 0.00% (As of May. 20, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Kilitch Drugs (India) Forward Dividend Yield %?

As of today (2025-05-20), the Forward Annual Dividend Yield of Kilitch Drugs (India) is 0.00%.

As of today (2025-05-20), the Trailing Annual Dividend Yield of Kilitch Drugs (India) is 0.00%.

BOM:524500's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.845
* Ranked among companies with meaningful Forward Dividend Yield % only.

Kilitch Drugs (India)'s Dividends per Share for the three months ended in Dec. 2024 was ₹0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Kilitch Drugs (India)'s Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Kilitch Drugs (India)'s Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kilitch Drugs (India)'s Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kilitch Drugs (India)'s Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Kilitch Drugs (India)'s Forward Dividend Yield % falls into.


;
;

Kilitch Drugs (India) Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Kilitch Drugs (India)  (BOM:524500) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Kilitch Drugs (India) Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Kilitch Drugs (India)'s Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kilitch Drugs (India) Business Description

Traded in Other Exchanges
Address
Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.

Kilitch Drugs (India) Headlines

No Headlines